While world public health agencies are focused on how to react to the next pandemic once it has started, a new plan proposes using ecological perspectives to prevent disease outbreaks before they happen.
Door-to-door surveillance surveys can provide more precise estimates of how many people are infected with COVID-19 or have immunity to COVID-19 at any given point in time than relying on self-reporting and self-testing, a Cornell-led research group has found.
Malnutrition of Indian children rose dramatically during the COVID-19 pandemic, according to new research from the Tata-Cornell Institute for Agriculture and Nutrition.
The inflammatory response from adaptive immune cells – such as B and T lymphocytes – clears the body of the SARS-CoV-2 virus, but at the same time, it also causes the characteristic symptoms of COVID-19, a new study finds.
For the first time in Cornell Engineering’s history, every school and department currently has, or will soon have, a woman faculty member on the college’s executive leadership team. The milestone comes as the college celebrates the 140th anniversary of its first woman engineer.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
New research used engineered mice to compare SARS-COV-2 omicron subvariants, and found one of them, BA.5, was more virulent likely due to its ability to rapidly replicate early during infection.
During the COVID-19 pandemic, many U.S. hospitals had overcapacity intensive care units while other area hospitals had open ICU beds available, a phenomenon known as “load imbalance.”
A team has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including omicron. Their discovery could lead to more potent vaccines and new antibody-based treatments.